Minerva Neurosciences, Inc. Stock Issued During Period, Shares, Conversion of Convertible Securities
Minerva Neurosciences, Inc. (NERV) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 352.00 thousand shares for the 0-month period ending 2014-07-07, per its 10-K filed 2017-03-13.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2017-03-13
- 2014-07-07: Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month 352.00K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month |
|---|---|
| 2014-07-07 | 352.00K shares 10-K · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |